All In Biotech

Free tool

FAERS Monitor: Lyrica Cr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209501 or its brand name (Lyrica Cr, Pregabalin). Reports on generic versions are filed under their own applications.

Reports

81,701

Serious

70,818

87% of reports

Hospitalization

33,840

Death reported

12,465

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective7,667
  • off label use5,813
  • fatigue5,735
  • pain5,131
  • nausea5,086
  • toxicity to various agents4,777
  • headache4,473
  • dyspnoea4,269
  • dizziness4,260
  • diarrhoea3,888
  • vomiting3,775
  • malaise3,495
  • arthralgia3,369
  • somnolence3,332
  • pyrexia3,222

Reports by year received

View as table
YearReports
20043
20054
200659
2007211
2008462
2009367
2010548
2011572
2012826
20131,053
20141,156
20151,630
20162,144
20172,596
20184,082
20195,849
20207,546
20218,337
20228,622
20238,290
20249,820
20259,917
20267,607

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,972,458 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
toxicity to various agentsSignal4,7777.57.326,242
somnolenceSignal3,3324.34.28,422
pyrexiaSignal3,2222.42.32,677
dizzinessSignal4,2602.22.12,862
painSignal5,1312.22.13,264
arthralgiaSignal3,3692.12.01,950
vomitingSignal3,7752.12.02,134
malaiseSignal3,4952.12.01,930
dyspnoea4,2691.91.92,009
fatigue5,7351.91.92,532
headache4,4731.81.81,763
off label use5,8131.71.71,790
nausea5,0861.71.61,372
diarrhoea3,8881.61.5787
drug ineffective7,6671.51.51,357

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.